United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $834,836,763.10
- April 17, 2025
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 15, 2016 | CEO | 1,258 | $122.34 | Sell | $153,903.72 | |
Sept. 8, 2016 | CEO | 1,254 | $123.44 | Sell | $154,793.76 | |
Sept. 1, 2016 | Director | 5,000 | $122.73 | Sell | $613,650.00 | |
Sept. 1, 2016 | CEO | 1,257 | $122.81 | Sell | $154,372.17 | |
Aug. 25, 2016 | CEO | 1,250 | $125.29 | Sell | $156,612.50 | |
Aug. 18, 2016 | CEO | 1,249 | $125.88 | Sell | $157,224.12 | |
Aug. 11, 2016 | CEO | 1,253 | $124.09 | Sell | $155,484.77 | |
Aug. 4, 2016 | CEO | 1,249 | $125.78 | Sell | $157,099.22 | |
July 28, 2016 | CEO | 1,271 | $117.05 | Sell | $148,770.55 | |
July 21, 2016 | CEO | 1,284 | $112.77 | Sell | $144,796.68 | |
July 14, 2016 | CEO | 1,292 | $110.05 | Sell | $142,184.60 | |
July 7, 2016 | CEO | 1,293 | $109.87 | Sell | $142,061.91 | |
June 30, 2016 | CEO | 1,308 | $105.10 | Sell | $137,470.80 | |
June 23, 2016 | CEO | 1,312 | $104.07 | Sell | $136,539.84 | |
June 16, 2016 | CEO | 1,308 | $105.18 | Sell | $137,575.44 | |
June 9, 2016 | CEO | 1,277 | $114.99 | Sell | $146,842.23 | |
June 8, 2016 | Director | 2,000 | $115.62 | Sell | $231,240.00 | |
June 2, 2016 | CEO | 1,261 | $120.79 | Sell | $152,316.19 | |
June 2, 2016 | Director | 3,000 | $118.82 | Sell | $356,460.00 | |
May 26, 2016 | CEO | 5,547 | $117.57 | Sell | $652,160.79 | |
May 19, 2016 | CEO | 5,546 | $110.75 | Sell | $614,219.50 | |
May 12, 2016 | CEO | 5,547 | $109.02 | Sell | $604,733.94 | |
May 12, 2016 | Director | 3,000 | $110.00 | Sell | $330,000.00 | |
May 5, 2016 | CEO | 5,546 | $107.79 | Sell | $597,803.34 | |
April 28, 2016 | CEO | 5,547 | $106.81 | Sell | $592,475.07 | |
April 21, 2016 | CEO | 5,546 | $115.74 | Sell | $641,894.04 | |
April 14, 2016 | CEO | 5,547 | $114.32 | Sell | $634,133.04 | |
April 7, 2016 | CEO | 5,546 | $113.31 | Sell | $628,417.26 | |
March 24, 2016 | CEO | 5,546 | $110.80 | Sell | $614,496.80 | |
March 17, 2016 | CEO | 5,547 | $118.22 | Sell | $655,766.34 | |
March 10, 2016 | CEO | 5,546 | $123.41 | Sell | $684,431.86 | |
March 3, 2016 | CEO | 5,547 | $126.78 | Sell | $703,248.66 | |
Feb. 25, 2016 | CEO | 5,546 | $122.45 | Sell | $679,107.70 | |
Feb. 18, 2016 | CEO | 5,547 | $128.26 | Sell | $711,458.22 | |
Feb. 11, 2016 | CEO | 5,546 | $120.47 | Sell | $668,126.62 | |
Feb. 4, 2016 | CEO | 5,547 | $122.13 | Sell | $677,455.11 | |
Feb. 4, 2016 | Director | 3,000 | $122.66 | Sell | $367,980.00 | |
Jan. 28, 2016 | CEO | 5,546 | $124.00 | Sell | $687,704.00 | |
Jan. 21, 2016 | CEO | 5,547 | $127.00 | Sell | $704,469.00 | |
Jan. 14, 2016 | CEO | 5,546 | $135.94 | Sell | $753,923.24 | |
Jan. 7, 2016 | Director | 3,000 | $143.75 | Sell | $431,250.00 | |
Jan. 7, 2016 | CEO | 5,547 | $145.84 | Sell | $808,974.48 | |
Dec. 24, 2015 | CEO | 5,546 | $159.58 | Sell | $885,030.68 | |
Dec. 17, 2015 | CEO | 5,546 | $158.49 | Sell | $878,985.54 | |
Dec. 10, 2015 | CEO | 5,546 | $154.49 | Sell | $856,801.54 | |
Dec. 3, 2015 | Director | 3,000 | $157.22 | Sell | $471,660.00 | |
Dec. 3, 2015 | CEO | 5,546 | $154.49 | Sell | $856,801.54 | |
Nov. 27, 2015 | CEO | 5,561 | $153.81 | Sell | $855,337.41 | |
Nov. 19, 2015 | CEO | 9,661 | $148.56 | Sell | $1,435,238.16 | |
Nov. 12, 2015 | CEO | 4,115 | $147.72 | Sell | $607,867.80 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Judy D. Olian, R Paul Gray, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, and DWEK RAYMOND
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on April 17, 2025.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.